|
2013-04-10 |
2013-04-08 |
V
Vente
|
LICHTINGER PEDRO
Former CEO
|
90 000
-46.4%
14,73
1 325 538 USD
|
90 000
-46.4%
|
14,73
|
1 325 538 USD
|
|
|
2013-04-10 |
2013-04-08 |
V
Vente
|
LICHTINGER PEDRO
Former CEO
|
58 000
-23.0%
14,63
848 453 USD
|
58 000
-23.0%
|
14,63
|
848 453 USD
|
|
|
2012-11-19 |
2012-11-08 |
A
Achat
|
LICHTINGER PEDRO
CEO and President
Dirigeant
|
11 000
+11.8%
9,08
99 847 USD
|
11 000
+11.8%
|
9,08
|
99 847 USD
|
|
|
2012-06-20 |
2012-06-11 |
V
Vente
|
CHANG JOSEPH Y
Administrateur non-exécutif
|
3 461
-3.3%
15,30
52 953 USD
|
3 461
-3.3%
|
15,30
|
52 953 USD
|
|
|
2011-08-09 |
2011-08-09 |
A
Achat
|
ALTIG ANTHONY E
Administrateur non-exécutif
|
5 000
+inf%
7,44
37 213 USD
|
5 000
+inf%
|
7,44
|
37 213 USD
|
|
|
2011-08-04 |
2011-08-04 |
A
Achat
|
LICHTINGER PEDRO
CEO and President
Administrateur exécutif
|
25 000
+38.0%
8,98
224 450 USD
|
25 000
+38.0%
|
8,98
|
224 450 USD
|
|
|
2010-05-13 |
2010-05-12 |
V
Vente
|
CHANG JOSEPH Y
Administrateur non-exécutif
|
3 461
-3.5%
11,75
40 667 USD
|
3 461
-3.5%
|
11,75
|
40 667 USD
|
|
|
2010-05-13 |
2010-05-12 |
V
Vente
|
CHANG JOSEPH Y
Administrateur non-exécutif
|
4 615
-4.6%
11,75
54 226 USD
|
4 615
-4.6%
|
11,75
|
54 226 USD
|
|
|
2009-12-29 |
2009-12-29 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
8 000
+3.8%
10,80
86 400 USD
|
8 000
+3.8%
|
10,80
|
86 400 USD
|
|
|
2009-12-29 |
2009-12-29 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
8 000
+3.8%
10,80
86 400 USD
|
8 000
+3.8%
|
10,80
|
86 400 USD
|
|
|
2009-12-29 |
2009-12-28 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
10 000
+4.9%
10,85
108 500 USD
|
10 000
+4.9%
|
10,85
|
108 500 USD
|
|
|
2009-12-29 |
2009-12-28 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
10 000
+4.9%
10,85
108 500 USD
|
10 000
+4.9%
|
10,85
|
108 500 USD
|
|
|
2009-12-02 |
2009-12-02 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
500
+0.6%
10,89
5 445 USD
|
500
+0.6%
|
10,89
|
5 445 USD
|
|
|
2009-12-02 |
2009-12-02 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
500
+0.6%
10,90
5 450 USD
|
500
+0.6%
|
10,90
|
5 450 USD
|
|
|
2009-12-02 |
2009-12-02 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
1 000
+1.2%
10,96
10 960 USD
|
1 000
+1.2%
|
10,96
|
10 960 USD
|
|
|
2009-12-02 |
2009-12-01 |
A
Achat
|
Shue Youe Kong
VP, Clinical Development
Dirigeant
|
1 000
+1.3%
11,10
11 100 USD
|
1 000
+1.3%
|
11,10
|
11 100 USD
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
7 000
+3.6%
11,50
80 500 USD
|
7 000
+3.6%
|
11,50
|
80 500 USD
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
7 000
+3.6%
11,50
80 500 USD
|
7 000
+3.6%
|
11,50
|
80 500 USD
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Che Tessie M
COO and SVP
Dirigeant
|
8 000
+4.3%
11,53
92 240 USD
|
8 000
+4.3%
|
11,53
|
92 240 USD
|
|
|
2009-11-25 |
2009-11-25 |
A
Achat
|
Chang Michael N
CEO and President
Administrateur exécutif
|
8 000
+4.3%
11,53
92 240 USD
|
8 000
+4.3%
|
11,53
|
92 240 USD
|
|
